Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being ...

The urine test, called MyProstateScore 2.0, or MPS2, looks at 18 different genes linked to high-grade prostate cancer. The researchers had previously demonstrated that the test was effective in ...

Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies.However, in addition to being uncomfortable, some of these ...

In a live event, Vinay Minocha, MD, discusses the addition of darolutamide to androgen deprivation therapy for in patients ...

Genomic tests are revolutionizing prostate cancer care, enabling precise, personalized treatment tailored to each patient.

In an interview with Peers & Perspectives in Oncology, Michael S. Leapman, MD, MHS, discusses the significance of a 10-year ...

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests — Decipher, Oncotype DX Genomic ...

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests - Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris - can help doctors make better decisions ...

Tissue-based genomic classifier tests, developed to improve prostate cancer risk assessment and treatment recommendations, ...

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests — Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris — can help doctors make better decisions ...

Among patients with high-risk disease (defined by absolute PSA level, Gleason score, and tumor category), estimated 7-year absolute risk for prostate-cancer mortality was 24% in those with PSA ...

Explore the role of the extracellular matrix (ECM) in prostate cancer progression and discover natural therapies, including ...